Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
-
Shares outstanding
-
266,212,950
-
Total 13F shares
-
168,313,648
-
Share change
-
-10,295,791
-
Total reported value
-
$395,039,824
-
Price per share
-
$2.35
-
Number of holders
-
106
-
Value change
-
-$37,132,339
-
Number of buys
-
50
-
Number of sells
-
43
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q4 2024
As of 31 Dec 2024,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
168,313,648 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Blackstone Inc., Syncona Portfolio Ltd, FMR LLC, Deep Track Capital, LP, Avoro Capital Advisors LLC, ARMISTICE CAPITAL, LLC, TFG Asset Management GP Ltd, Frazier Life Sciences Management, L.P., and Affinity Asset Advisors, LLC.
This page lists
107
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.